Researchers assessed the effects of inpatient treatment with zoledronic acid on mortality rates and subsequent fracture risk.

Title: AGA2118, a Bispecific Antibody Neutralizing Both Sclerostin and DKK1, Increased Bone Formation and Decreased Bone Resorption, Leading to a Rapid Increase in Bone Mass and Strength in an ...

But your friend is also half wrong. When used appropriately, Fosamax and other bisphosphonate drugs are effective at reducing the risk of fractures. A vertebral body fracture can cause years of pain ...

Netherlands: A new study, published in Diabetes, Obesity and Metabolism sheds light on how various characteristics of type 2 ...

Although differentiation and activity of bone-forming osteoblasts are regulated at various levels, there is ample evidence ...

Global Orthopedic Imaging Equipment Market is valued at approximately USD 4.68 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.10% over the forecast period ...

World Physical Therapy Day on 8 Sept 2024 underscores the significance of physiotherapy in osteoporosis management. The ...

In response to the growing burden of osteoporosis-associated fractures, the International Osteoporosis Foundation ...

Launches Groundbreaking Clinical Guidelines to Combat Growing Public Health Burden HONG KONG SAR – Media OutReach Newswire – ...